Native structure protects SUMO proteins from aggregation into amyloid fibrils.

SUMO proteins belong to the Ubiquitin-like protein family, all sharing a common fold and a similar mechanism of conjugation to target polypeptides. SUMO is ubiquitous in all eukaryotes and participates in many crucial pathways. Native SUMO proteins are highly soluble, a property that is exploited in biotechnology. Moreover, SUMO regulates the solubility of aggregation-prone proteins in neurodegenerative disorders. Despite these properties, we show here that human SUMO1, SUMO2, and SUMO3 proteins are at risk of aggregation into amyloid structures if their native conformation is perturbed. Aggregation is mediated by specific regions, which overlap with SUMO functional interfaces, illustrating a competition between function and aggregation. Aggregation of SUMOs might have important physiological implications because disruption of the SUMO pathway is lethal in different organisms. It appears that functional constraints make it difficult to avoid the competition between productive folding and deleterious aggregation in globular proteins, even for essential polypeptides.

[1]  Michele Vendruscolo,et al.  Life on the edge: a link between gene expression levels and aggregation rates of human proteins. , 2007, Trends in biochemical sciences.

[2]  F. Melchior,et al.  Concepts in sumoylation: a decade on , 2007, Nature Reviews Molecular Cell Biology.

[3]  Francesc X. Avilés,et al.  AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides , 2007, BMC Bioinform..

[4]  Sheena E Radford,et al.  The Yin and Yang of protein folding , 2005, The FEBS journal.

[5]  S. Kügler,et al.  Sumoylation inhibits α-synuclein aggregation and toxicity , 2011, The Journal of cell biology.

[6]  T. Butt,et al.  SUMO fusion technology for enhanced protein expression and purification in prokaryotes and eukaryotes. , 2011, Methods in molecular biology.

[7]  Michele Vendruscolo,et al.  Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins , 2009, Proceedings of the National Academy of Sciences.

[8]  Ming Yan,et al.  SUMO-1 modification increases human SOD1 stability and aggregation , 2006, Neurosciences research.

[9]  C. Duyckaerts,et al.  SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7. , 2010, Human molecular genetics.

[10]  F. Avilés,et al.  Ile-phe dipeptide self-assembly: clues to amyloid formation. , 2007, Biophysical journal.

[11]  David Eisenberg,et al.  Recent atomic models of amyloid fibril structure. , 2006, Current opinion in structural biology.

[12]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[13]  A. Velázquez‐Campoy,et al.  Contribution of disulfide bonds to stability, folding, and amyloid fibril formation: the PI3-SH3 domain case. , 2012, Antioxidants & redox signaling.

[14]  F. Avilés,et al.  Designing out disulfide bonds of leech carboxypeptidase inhibitor: implications for its folding, stability and function. , 2009, Journal of molecular biology.

[15]  Heeyoung Jung,et al.  CSSP2: An improved method for predicting contact-dependent secondary structure propensity , 2007, Comput. Biol. Chem..

[16]  Silvio C. E. Tosatto,et al.  The PASTA server for protein aggregation prediction. , 2007, Protein engineering, design & selection : PEDS.

[17]  Fabrizio Chiti,et al.  Prevention of amyloid‐like aggregation as a driving force of protein evolution , 2007, EMBO reports.

[18]  T. Pellegrino,et al.  Copper-Triggered Aggregation of Ubiquitin , 2009, PloS one.

[19]  Michele Vendruscolo,et al.  Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.

[20]  Wen-Chen Huang,et al.  Crystal structures of the human SUMO-2 protein at 1.6 A and 1.2 A resolution: implication on the functional differences of SUMO proteins. , 2004, European journal of biochemistry.

[21]  C. Dobson.  Protein folding and misfolding , 2003, Nature.

[22]  C. Dobson,et al.  Preparation and characterization of purified amyloid fibrils. , 2001, Journal of the American Chemical Society.

[23]  R. Hay,et al.  SUMO: a history of modification. , 2005, Molecular cell.

[24]  Ziming Zhang,et al.  Small Ubiquitin-like Modifier (SUMO) Recognition of a SUMO Binding Motif , 2005, Journal of Biological Chemistry.

[25]  P. Lansbury,et al.  Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. , 1992, Biochemistry.

[26]  Salvador Ventura,et al.  Protein Aggregation Profile of the Bacterial Cytosol , 2010, PloS one.

[27]  Erica S. Johnson,et al.  Protein modification by SUMO. , 2004, Annual review of biochemistry.

[28]  Amedeo Caflisch,et al.  Computational analysis of the S. cerevisiae proteome reveals the function and cellular localization of the least and most amyloidogenic proteins , 2007, Proteins.

[29]  Fumio Hanaoka,et al.  Crystal structure of thymine DNA glycosylase conjugated to SUMO-1 , 2005, Nature.

[30]  Salvador Ventura,et al.  Amyloidogenic Regions and Interaction Surfaces Overlap in Globular Proteins Related to Conformational Diseases , 2009, PLoS Comput. Biol..

[31]  Michele Vendruscolo,et al.  Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions , 2011, Cell.

[32]  L. Serrano,et al.  A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. , 2004, Journal of molecular biology.

[33]  Raimon Sabate,et al.  Prediction of the aggregation propensity of proteins from the primary sequence: Aggregation properties of proteomes , 2011, Biotechnology journal.

[34]  Christopher M Dobson,et al.  Principles of protein folding, misfolding and aggregation. , 2004, Seminars in cell & developmental biology.

[35]  R. Sabaté,et al.  An autocatalytic reaction as a model for the kinetics of the aggregation of β‐amyloid , 2003, Biopolymers.

[36]  David Owerbach,et al.  A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. , 2005, Biochemical and biophysical research communications.

[37]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[38]  David Eisenberg,et al.  A systematic screen of β2-microglobulin and insulin for amyloid-like segments , 2006 .

[39]  Salvador Ventura,et al.  Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Vendruscolo,et al.  The Zyggregator method for predicting protein aggregation propensities. , 2008, Chemical Society reviews.

[41]  J. Pettegrew,et al.  Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  A. Fersht,et al.  Protein folding and binding: moving into unchartered territory. , 2009, Current opinion in structural biology.

[43]  C. Bugg,et al.  Structure of ubiquitin refined at 1.8 A resolution. , 1987, Journal of molecular biology.

[44]  H. Levine,et al.  Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.

[45]  J. Iñiguez-Lluhí,et al.  Small Ubiquitin-like Modifier (SUMO) Modification of the Androgen Receptor Attenuates Polyglutamine-mediated Aggregation*♦ , 2009, The Journal of Biological Chemistry.

[46]  F. Melchior,et al.  Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association. , 2005, Molecular biology of the cell.

[47]  Nikolay V Dokholyan,et al.  Natural selection against protein aggregation on self-interacting and essential proteins in yeast, fly, and worm. , 2008, Molecular biology and evolution.

[48]  Ivan Dikic,et al.  Specification of SUMO1- and SUMO2-interacting Motifs* , 2006, Journal of Biological Chemistry.

[49]  S. Hamodrakas.  Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies , 2011, The FEBS journal.

[50]  David Reverter,et al.  Insights into E3 ligase activity revealed by a SUMO–RanGAP1–Ubc9–Nup358 complex , 2005, Nature.

[51]  Frederic Rousseau,et al.  How evolutionary pressure against protein aggregation shaped chaperone specificity. , 2006, Journal of molecular biology.

[52]  C. Dobson,et al.  Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. , 2001, Journal of molecular biology.

[53]  M. Hochstrasser,et al.  A new protease required for cell-cycle progression in yeast , 1999, Nature.

[54]  R. Sabaté,et al.  Amyloids in bacterial inclusion bodies. , 2009, Trends in biochemical sciences.

[55]  S. Li,et al.  Insights into High Affinity Small Ubiquitin-like Modifier (SUMO) Recognition by SUMO-interacting Motifs (SIMs) Revealed by a Combination of NMR and Peptide Array Analysis* , 2011, The Journal of Biological Chemistry.

[56]  Alexander Varshavsky,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[57]  J. Henley,et al.  Mechanisms, regulation and consequences of protein SUMOylation. , 2010, The Biochemical journal.

[58]  A. Pastore,et al.  The two faces of Janus: functional interactions and protein aggregation. , 2012, Current opinion in structural biology.

[59]  Michele Vendruscolo,et al.  Functional interactions as a survival strategy against abnormal aggregation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  Caroline Louis-Jeune,et al.  Prediction of protein secondary structure from circular dichroism using theoretically derived spectra , 2012, Proteins.

[61]  T. A. Wilkinson,et al.  Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Sumoylation inhibits a-synuclein aggregation and toxicity , 2011 .

[63]  T. Ikegami,et al.  Structure of the Small Ubiquitin-like Modifier (SUMO)-interacting Motif of MBD1-containing Chromatin-associated Factor 1 Bound to SUMO-3* , 2008, Journal of Biological Chemistry.